Novel SNP improves differential survivability and mortality in non-small cell lung cancer patients

BACKGROUND: Non-small cell lung cancer (NSCLC) is a major cause of cancer-related death worldwide due to poor patient prognosis and clinical outcome. Here, we studied the genetic variations underlying NSCLC pathogenesis based on their association to patient outcome after gemcitabine therapy. RESULTS...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:BMC Genomics
Main Authors: Mah, Tzia Liang, Yap, Xin Ning Adeline, Limviphuvadh, Vachiranee, Li, Nanpu, Sridharan, Srinath, Kuralmani, Vellaisemy, Feng, Mengling, Liem, Natalia, Adhikari, Sharmila, Yong, Wei Peng, Soo, Ross A, Maurer-Stroh, Sebastian, Eisenhaber, Frank, Tong, Joo Chuan
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2014
נושאים:
Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4290611/
https://ncbi.nlm.nih.gov/pubmed/25521664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2164-15-S9-S20
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים